Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Jones

Showing results (311-320 of 463) with videos related to

Pageof 47
Sort By:
Pharmaceutical Research|August 24, 2016
Erratum to: Characterization of Pharmacokinetics in the Göttingen Minipig with Reference Human Drugs: An In Vitro and In Vivo ApproachFloriane Lignet, Eva Sherbetjian, Nicole Kratochwil, et al.
The British Journal of Dermatology|May 22, 2001
A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphomaJ J Scarisbrick, F J Child, A Clift, et al.
The British Journal of Dermatology|March 26, 2003
Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UKF J Child, T J Mitchell, S J Whittaker, et al.
Diabetes, Obesity & Metabolism|August 7, 2012
Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programmeK Niswender, X Pi-Sunyer, J Buse, et al.
Cancer Chemotherapy and Pharmacology|May 8, 2019
A single-center, open-label study investigating the excretion balance, pharmacokinetics, metabolism, and absolute bioavailability of a single oral dose of [<sup>14</sup>C]-labeled idasanutlin and an intravenous tracer dose of [<sup>13</sup>C]-labeled idasanutlin in a single cohort of patients with solid tumorsZsuzsanna Pápai, Lin-Chi Chen, Daniel Da Costa, et al.
Clinical and Experimental Dermatology|April 30, 2004
A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoidesF J Child, T J Mitchell, S J Whittaker, et al.
The American Journal of Physiology|March 10, 1999
A surrogate measure of whole body leucine transport across the cell membraneR Hovorka, P V Carroll, I J Gowrie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanomaK M Acland, C Healy, E Calonje, et al.
Archives of Dermatology|November 24, 1999
Secondary malignant neoplasms in 71 patients with Sézary syndromeJ J Scarisbrick, F J Child, A V Evans, et al.
European Journal of Endocrinology|June 1, 2002
Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?A G Hatrick, P Boghalo, J B Bingham, et al.
Pageof 47

Showing results (311-320 of 463) with videos related to

Sort By:
Pageof 47
Pharmaceutical Research|August 24, 2016
Erratum to: Characterization of Pharmacokinetics in the Göttingen Minipig with Reference Human Drugs: An In Vitro and In Vivo ApproachFloriane Lignet, Eva Sherbetjian, Nicole Kratochwil, et al.
The British Journal of Dermatology|May 22, 2001
A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphomaJ J Scarisbrick, F J Child, A Clift, et al.
The British Journal of Dermatology|March 26, 2003
Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UKF J Child, T J Mitchell, S J Whittaker, et al.
Diabetes, Obesity & Metabolism|August 7, 2012
Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programmeK Niswender, X Pi-Sunyer, J Buse, et al.
Cancer Chemotherapy and Pharmacology|May 8, 2019
A single-center, open-label study investigating the excretion balance, pharmacokinetics, metabolism, and absolute bioavailability of a single oral dose of [<sup>14</sup>C]-labeled idasanutlin and an intravenous tracer dose of [<sup>13</sup>C]-labeled idasanutlin in a single cohort of patients with solid tumorsZsuzsanna Pápai, Lin-Chi Chen, Daniel Da Costa, et al.
Clinical and Experimental Dermatology|April 30, 2004
A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoidesF J Child, T J Mitchell, S J Whittaker, et al.
The American Journal of Physiology|March 10, 1999
A surrogate measure of whole body leucine transport across the cell membraneR Hovorka, P V Carroll, I J Gowrie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanomaK M Acland, C Healy, E Calonje, et al.
Archives of Dermatology|November 24, 1999
Secondary malignant neoplasms in 71 patients with Sézary syndromeJ J Scarisbrick, F J Child, A V Evans, et al.
European Journal of Endocrinology|June 1, 2002
Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?A G Hatrick, P Boghalo, J B Bingham, et al.
Pageof 47